Global Dosimetry Solutions, Inc., Names Tom Logan as Chief Executive Officer COSTA MESA, Calif., May 13 /PRNewswire/ -- Global Dosimetry Solutions, Inc. a leading provider of dosimetry services (analytical determination of exposure to ionizing radiation) has announced the appointment of Tom Logan as Chief Executive Officer (CEO). The new appointment was made following the company's announcement that Sandra (Sandi) Nemecek, the company's president and a founding employee plans to retire at the end of this year. Logan joins GDS after having served as its Chief Transition Officer in conjunction with the purchase of GDS by American Capital Strategies (NASDAQ:ACAS) from Valeant Pharmaceutical. With more than 20 years of experience in global manufacturing, Logan has held senior operating and financial roles within the contract manufacturing, consumer products and integrated energy industries. He is the former Chairman of the Board of the Association for Financial Professionals, and is a current Board member of the New Piper Aircraft Corporation. Logan holds a bachelor of science degree and a master's degree in business from Cornell University. "Global Dosimetry Solutions has a reputation for providing the highest level of customer service in the industry, and we look forward to enhancing and extending that reputation in the months and years ahead," said Logan. "I am delighted to have the opportunity to work with the finest team in the industry as we pursue these goals on behalf of our many customers." "Tom brings tremendous experience in managing high-volume industrial businesses, has extensive international experience and a great leadership style, which will serve our customers and employees well," said Robert Klein, Managing Director of American Capital. "We look forward to continued growth and exceptional results under Tom's leadership." About Global Dosimetry Solutions Global Dosimetry Solutions, based in Costa Mesa, California, is one of the world's largest providers of radiation dosimetry services. GDS offers a full range of services for measuring ionizing radiation primarily through film, thermoluminescent and track etch technologies. Since early 1970, the company has continually provided state-of-the-art personal radiation monitoring services to hospitals, medical and dental offices, university and national laboratories, nuclear power plants and other industries. GDS provides services to more than 500,000 people globally. For more information, please visit: http://www.dosimetry.com/. About American Capital Strategies, Ltd. American Capital is a publicly traded buyout and mezzanine fund with capital resources in excess of $2.7 billion. American Capital is an investor in and sponsor of management and employee buyouts; invests in private equity sponsored buyouts, and provides capital directly to private and small public companies. American Capital provides senior debt, mezzanine debt and equity to fund growth, acquisitions and recapitalizations. Companies interested in learning more about American Capital's flexible financing should contact Mark Opel, Principal, at (800) 248-9340, or visit their website. DATASOURCE: Global Dosimetry Solutions, Inc. CONTACT: Monica Golden of True Parallel, +1-714-273-2776, , for Global Dosimetry Solutions, Inc. Web site: http://www.dosimetry.com/

Copyright

American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 American Capital Strategies 차트를 더 보려면 여기를 클릭.
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 American Capital Strategies 차트를 더 보려면 여기를 클릭.